Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

19.25
Real-Time Quote
As of 2:20pm ET
 -1.48 / -7.14%
Today’s Change
18.45
Today|||52-Week Range
24.75
-7.89%
Year-to-Date
Can NewLink Genetics Win the Zika Vaccine Race?
10:07am / MotleyFool.com
Can GlaxoSmithKline (GSK) Q4 Earnings Surprise Estimates?
Feb 01 / Zacks.com
3 Pharma Stocks to Heal Your Portfolio
6:02am / TheStreet.com
Novice Trade: GlaxoSmithKline
Feb 01 / TheStreet.com
Why Ionis Pharmaceuticals Inc Plunged 36% in January
Feb 06 / MotleyFool.com
Rally Hobbled As Ugly China Reality Replaces Japan NIRP Euphoria; Oil Rebound Fizzles
Feb 01 / Investing Channel
4 Can't-Miss Numbers From GlaxoSmithKline's Fourth-Quarter Results
Feb 04 / MotleyFool.com
3 Feverishly Bad Flu Myths That Should Be Put to Rest
Jan 31 / MotleyFool.com
Is Inovio Pharmaceuticals' Zika Surge Premature?
Feb 04 / MotleyFool.com
The 3 Most Important Numbers When GlaxoSmithKline Reports Its Fourth-Quarter Results
Jan 29 / MotleyFool.com
Glaxo Tops Q4 Earnings, Revenues Rise Y/Y, 2016 View Intact
Feb 04 / Zacks.com
CDXS and LOGI are Aggressive Growth Stocks
Jan 28 / Zacks.com
Frontrunning: February 4
Feb 04 / Investing Channel
Novartis (NVS) Lags Q4 Earnings & Revenues, Alcon Down
Jan 28 / Zacks.com
GlaxoSmithKline (GSK) Earnings Report: Q4 2015 Conference Call Transcript
Feb 04 / TheStreet.com
Is Another Big Transformation on the Way for GlaxoSmithKline?
Jan 28 / MotleyFool.com
3 Value Stocks Near 52-Week Lows Worth Buying
Feb 04 / MotleyFool.com
OncoMed Tanks on Phase II Pancreatic Cancer Study Update
Jan 27 / Zacks.com
3 Stocks Driving The Drugs Industry Higher
Feb 03 / TheStreet.com
Novartis (NVS) Posts Lower-Than-Expected Earnings in Q4
Jan 27 / Zacks.com
3 Hold-Rated Dividend Stocks: QCOM, MDC, GSK
Feb 03 / TheStreet.com
Forget Pfizer Inc.: Here Are 2 Better Dividend Stocks
Jan 26 / MotleyFool.com
Glaxo (GSK) Beats on Q4 Earnings, Revenues Rise Y/Y
Feb 03 / Zacks.com
Why OncoMed Pharmaceuticals' Stock Crashed Today
Jan 25 / MotleyFool.com
GlaxoSmithKline (GSK) Strong In Pre-Market Trading
Feb 03 / TheStreet.com
Investors are terrified ... and they're overreacting
Jan 15 / CNNMoney.com
Why Axovant Sciences Shares Are Crashing
Feb 02 / MotleyFool.com